Qualigen Therapeutics, Inc. — Director's Dealing 2017

Jan 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RITTER PHARMACEUTICALS INC (RTTR)
CIK: 0001460702
Period of Report: 2017-01-25

Reporting Person: Step Michael D (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-25	Non-qualified Stock Option (Right to Buy)	$2.89	A	58000	Acquired	2027-01-25	Common Stock (58000)	Direct

Footnotes

F1: The option vests in forty-eight (48) equal monthly installments beginning on February 25, 2017 with the balance vesting on the 25th day of each calendar month thereafter until vested in full.